Population
Women with ischemic heart disease or ischemic symptoms, particularly those without flow-limiting epicardial…
Design
Review
Key result
A mechanism-based framework integrating female-specific biological factors and coronary phenotyping is proposed to support precise diagnosis and individualized treatment of IHD in women.
Authors
Loading...
Clinicians should assess symptomatic women for microvascular dysfunction, vasospasm, and SCAD; extends evidence to support sex-specific IHD evaluation and management.
Proposes a clinically oriented, mechanism-based framework for diagnosing and managing ischemic heart disease in women, emphasizing non-obstructive causes such as microvascular dysfunction, vasospasm, and SCAD.
Tognola et al. (2026) conducted a review in Ischemic heart disease in women. A mechanism-based framework integrating female-specific biological factors and coronary phenotyping is proposed to support precise diagnosis and individualized treatment of IHD in women.